VanEck Biotech ETF Rating $166.85 +1.81 (+1.10%) Closing price 08/15/2025 03:59 PM EasternExtended Trading$166.85 0.00 (0.00%) As of 08/15/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy 2.65Holdings in BBH have an aggregate rating of Moderate Buy based on 485 analyst ratings issued in the past year covering 24 companies (100.0% of the portfolio).BBH Aggregate Price Target$166.85High Prediction$166.85Average Prediction$166.85Low Prediction$166.85Holdings in BBH have an aggregate price target of $166.85 and a range of $166.85 to $166.85 covering 24 companies (100.0% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BBH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.18%AMGNAmgen$296.47+2.1%4.6642 of 5 stars2.33$303.76 2.5%21Trending NewsAnalyst Revision12.65%GILDGilead Sciences$118.37-0.5%4.8511 of 5 stars2.80$114.82 -3.0%25Positive NewsDividend AnnouncementAnalyst Revision10.43%VRTXVertex Pharmaceuticals$392.79+0.6%4.948 of 5 stars2.56$497.10 26.6%27Positive News5.34%IQVIQVIA$191.18+0.9%4.9164 of 5 stars2.74$228.62 19.6%23News CoveragePositive NewsShort Interest ↓Analyst Revision5.11%REGNRegeneron Pharmaceuticals$580.41+2.6%4.8391 of 5 stars2.81$829.65 42.9%26News CoveragePositive NewsDividend AnnouncementAnalyst ForecastAnalyst RevisionGap Up4.83%ARGXargenex$653.83+0.2%3.966 of 5 stars3.10$746.81 14.2%20Positive News4.64%ALNYAlnylam Pharmaceuticals$448.91+1.4%4.2615 of 5 stars2.85$405.33 -9.7%26Positive NewsInsider Trade3.99%ICLRIcon$175.84+0.3%4.2931 of 5 stars2.81$219.54 24.9%16Analyst Revision3.57%NTRANatera$163.02+2.9%3.2348 of 5 stars3.06$193.19 18.5%18News CoverageAnalyst ForecastInsider Trade3.48%INSMInsmed$127.80+0.0%4.1182 of 5 stars2.94$129.57 1.4%16Trending NewsAnalyst ForecastAnalyst Revision3.37%BIIBBiogen$138.60+2.7%4.863 of 5 stars2.34$185.74 34.0%32Analyst ForecastAnalyst Revision3.15%ILMNIllumina$100.11+0.0%4.5336 of 5 stars2.25$124.58 24.4%20News CoverageAnalyst Downgrade3.09%ONCBeOne Medicines$321.36+3.8%0.7962 of 5 stars3.00$330.89 3.0%7Insider Trade2.97%BNTXBioNTech$113.52+0.7%1.621 of 5 stars2.76$135.80 19.6%17Analyst ForecastAnalyst Revision2.77%NBIXNeurocrine Biosciences$132.90+1.2%4.8581 of 5 stars2.86$160.90 21.1%22Positive News2.69%MRNAModerna$28.02+5.0%4.3958 of 5 stars2.04$43.59 55.6%24Options Volume1.98%INCYIncyte$86.92+0.9%4.6564 of 5 stars2.33$81.20 -6.6%18Trending News1.87%TECHBio-Techne$53.60-0.3%4.9586 of 5 stars2.62$69.42 29.5%13Positive NewsDividend Announcement1.75%CRLCharles River Laboratories International$156.66+0.6%4.7906 of 5 stars2.27$175.69 12.1%15Positive News1.72%QGENQiagen$49.36+0.8%3.6592 of 5 stars2.27$49.69 0.7%11News Coverage1.54%BMRNBioMarin Pharmaceutical$57.54-0.8%4.9979 of 5 stars2.75$93.17 61.9%24Positive News1.34%EXASExact Sciences$45.60+1.4%4.8525 of 5 stars2.92$67.43 47.9%24News CoverageAnalyst Forecast1.26%RGENRepligen$124.35-1.8%4.8462 of 5 stars2.73$169.45 36.3%11Positive NewsInsider Trade0.25%SRPTSarepta Therapeutics$21.81+7.4%4.6031 of 5 stars2.07$43.63 100.0%29Trending NewsAnalyst ForecastShort Interest ↑ This page (NASDAQ:BBH) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredJPMorgan: Gold to $4,250—Here’s the Real PlayGold Surges And Some Investors Are Getting Paid, But Most Are Not. Which One Do You Want to Be? Gold prices ar...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access